Dergiler / GORM:Gynecology Obstetrics & Reproductive Medicine / 2018 / Cilt: 24 - Sayı: 2

Recurrence Pattern after Adjuvant Radiotherapy for Endometrioid Type Endometrial Cancer

Sayfa
92–98
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

CONCLUSION: Radiotherapy provides local control of the disease, but recurrence is likely to be extrapelvic and extra-abdominal in this patient group.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVE: To define recurrence pattern of endometrioid type endometrium cancer performed adjuvant radiotherapy.
📊
Temel Bulgular & Veri:STUDY DESIGN: 351 patients who underwent at least total abdominal hysterectomy with bilateral salpingo- oophorectomy and followed by adjuvant radiotherapy (vaginal brachytherapy or pelvic radiotherapy or both) for endometrioid type endometrium carcinoma were included.
💡
Sonuç & Katkı:CONCLUSION: Radiotherapy provides local control of the disease, but recurrence is likely to be extrapelvic and extra-abdominal in this patient group.
🔬Tür:Araştırma Makalesi
📍Kapsam:2009 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

OBJECTIVE: To define recurrence pattern of endometrioid type endometrium cancer performed adjuvant radiotherapy. STUDY DESIGN: 351 patients who underwent at least total abdominal hysterectomy with bilateral salpingo- oophorectomy and followed by adjuvant radiotherapy (vaginal brachytherapy or pelvic radiotherapy or both) for endometrioid type endometrium carcinoma were included. The patients who received systemic adjuvant treatment after surgery were excluded from the study except for 18 patients who received concomitant chemo-radiotherapy. Recurrence was categorized as pelvic recurrence included areas distal to the pelvic inlet, as abdominal recurrence included areas between pelvic inlet and diaphragm and findings such as ascites and peritonitis carcinomatosa, and the rest of recurrences including lung, cutaneous, liver parenchyma and bone as extra-abdominal recurrence. RESULTS: The median age was 57 years (range; 29-82). 236 patients had stage I, 25 had stage II, 63 had stage III and 14 had stage IV disease (by FIGO 2009). Lymph node metastasis was determined in 21.8% of patients who underwent lymphadenectomy (n: 289). The median follow-up time was 46 months (range; 1-190). Throughout follow-up, recurrence was developed in 55 (15.7%) patients. Only pelvic recurrence was determined in 11 (3.1%) patients. There was recurrence beyond the pelvis in 44 (80%) of the recurrent patients. Thirty-five (%63.6) of recurrent patients had extra-abdominal recurrence. Twentythree (41.8%) of recurrent patients had stage IB disease. The recurrence developed in 10% of patients with stage I&II, whereas it was occurred in 31% of patients with stage III&IV (p<0.0001). CONCLUSION: Radiotherapy provides local control of the disease, but recurrence is likely to be extrapelvic and extra-abdominal in this patient group.

🔖

Bu Makaleye Atıf Yap

DURMUŞ, Y., TÜRKMEN, O., KILIÇ, Ç. T., CÖMERT, G. K., AYTEKİN, O., FADILOĞLU, E., YIRCI, B., BAŞARAN, D., KARALOK, A., TURAN, T. A. (2018). Recurrence Pattern after Adjuvant Radiotherapy for Endometrioid Type Endometrial Cancer. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 24 - Sayı: 2, 92–98. https://ajindex.com/articles/162583

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11, Lyon, France: International Agency for Research on Cancer. Available from http://globocan. iarc.fr2013
  2. Lewin SN, Herzog TJ, Barrena Medel NI, Deutsch I, Burke WM, Sun X, et al. Comparative performance of the 2009 International Federation of Gynecology and Obstetrics’ staging system for uterine corpus cancer. Obstet Gynecol 2010;116(5):1141-9
  3. Aalders JG, Abeler V, Kolstad P. Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol Oncol 1984;17(1):85-103
  4. Fung-Kee-Fung M, Dodge J, Elit L, Lukka H, Chambers A, Oliver T. Follow-up after primary therapy for endometrial cancer: A systematic review. Gynecol Oncol 2006;10(3):520-9
  5. Huang HJ, Tang YH, Chou HH, Yang LY, Chao A, Huang YT, et al. Treatment failure in endometrial carcinoma. Int J Gynecol Cancer 2014;24(5):885-93
  6. Sorbe B, Juresta C, Ahlin C. Natural history of recurrences in endometrial carcinoma. Oncol Lett 2014;8(4):1800-6
  7. Descamps P, Calais G, Moire C, Bertrand P, Castiel M, Le Floch O, et al. Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy. Gynecol Oncol 1997; 64(1):54-8
  8. Turan T, Ureyen I, Duzguner I, Ozkaya E, Tasci T, Kara - lok A, et al. Analysis of patients with stage IIIC endometrial cancer. Int J Gynecol Cancer 2014;24(6):1033-41
  9. Bendifallah S, Ouldamer L, Lavoue V, Canlorbe G, Raimond E, Coutant C, et al. Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group. Gynecol Oncol 2017;144(1):107-12
  10. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000;355(9213):1404-11
  11. Gadducci A, Cosio S, Landoni F, Maggino T, Zola P, Sostegni B, et al. Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: An Italian multicenter retrospective study (CTF study). Gynecol Oncol 2014;134(1):29-35
  12. Creutzberg CL, Nout RA, Lybeert ML